journal
https://read.qxmd.com/read/38097010/metformin-treatment-is-associated-with-improved-survival-in-diabetic-patients-hospitalized-with-acute-heart-failure-a-prospective-observational-study-using-the-korean-acute-heart-failure-registry-data
#21
JOURNAL ARTICLE
Kyeong-Hyeon Chun, Jaewon Oh, Chan Joo Lee, Jin Joo Park, Sang Eun Lee, Min-Seok Kim, Hyun-Jai Cho, Jin-Oh Choi, Hae-Young Lee, Kyung-Kuk Hwang, Kye Hun Kim, Byung-Su Yoo, Dong-Ju Choi, Sang Hong Baek, Eun-Seok Jeon, Jae-Joong Kim, Myeong-Chan Cho, Shung Chull Chae, Byung-Hee Oh, Seok-Min Kang
AIMS: Although the hypothesis that metformin is beneficial for patients with diabetes and heart failure (HF) has been steadily raised, there is limited data on metformin use in patients with acute HF. We analyzed the association of metformin on all-cause mortality in hospitalized patients with type 2 diabetes and acute HF. METHODS: The Korean Acute Heart Failure registry prospectively enrolled patients hospitalized for acute HF from 2011 to 2014. Among this cohort, we analyzed patients with diabetes with baseline estimated glomerular filtration rate (eGFR) of 30 ml/min/1...
December 12, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/38065522/monitoring-gestational-diabetes-mellitus-patients-with-mydiabby-healthcare%C3%A2-smartphone-application-vs-classical-diary-results-from-the-non-inferiority-telesur-gdm-study
#22
JOURNAL ARTICLE
Poncelet C, Bouamoud L, Michel P, Campinos C
OBJECTIVE: The aim of the TELESUR-GDM study was to demonstrate the non-inferiority of the onset of maternal, fœtal, and neonatal complications for patients with gestational diabetes mellitus (GDM) monitored by myDiabby Healthcareࣨ (app group) compared to patients with a classical glycaemic blood monitoring by diary (control group). MATERIALS AND METHODS: TELESUR-GDM was a retrospective, monocentric, and non-inferiority study including 349 patients in the app group and 295 patients in the control group...
December 6, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/38036055/a-healthful-plant-based-diet-is-associated-with-lower-type-2-diabetes-risk-via-improved-metabolic-state-and-organ-function-a-prospective-cohort-study
#23
JOURNAL ARTICLE
Alysha S Thompson, Catharina J Candussi, Anna Tresserra-Rimbau, Amy Jennings, Nicola P Bondonno, Claire Hill, Solomon A Sowah, Aedín Cassidy, Tilman Kühn
BACKGROUND: Plant-based diets are becoming increasingly popular due to favourable environmental footprints and have been associated with lower risk of type 2 diabetes mellitus (T2DM). Here, we investigated the potential mechanisms to explain the lower T2DM risk observed among individuals following plant-based diets. METHODS: Prospective data from the UK Biobank, a cohort study of participants aged 40 to 69 years at baseline, was evaluated. Associations between healthful and unhealthful plant-based indices (hPDI and uPDI) and T2DM risk were analysed by multivariable Cox regression models, followed by causal mediation analyses to investigate which cardiometabolic risk factors explained the observed associations...
November 28, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/38036054/effects-of-sglt2-inhibitors-on-clinical-cancer-survival-in-patients-with-type-2-diabetes
#24
JOURNAL ARTICLE
Yen-Min Huang, Wan-Ming Chen, An-Tzu Jao, Mingchih Chen, Ben-Chang Shia, Szu-Yuan Wu
PURPOSE: According to the preclinical data, sodium-glucose cotransporter 2 (SGLT2) inhibitors (SGLT2is) may exert anticancer effects. Here, we clarified the cancer-specific mortality (primary outcome) and all-cause mortality (secondary outcome) of SGLT2is and their dose-dependency in patients with cancer undergoing standard curative treatments. METHODS: We analyzed data from patients with type 2 diabetes mellitus (T2DM) diagnosed with cancer between January 1, 2016, and December 31, 2018, enrolled from the Taiwan Cancer Registry database...
November 28, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/38000505/low-frequency-of-albuminuria-testing-among-diabetic-patients-in-france-real-world-data-from-clinical-laboratories
#25
LETTER
Fabrice Bonnet, Léa Longepierre, Dinh-Phong Nguyen, Imène Sedrati, Alegria Marcilla
No abstract text is available yet for this article.
November 23, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/38000504/french-national-authority-for-health-assessment-of-metabolic-surgery-for-type-2-diabetes-remission-a-meta-analysis-in-patients-with-class-i-to-iii-obesity
#26
REVIEW
Jean-Charles Lafarge, Judith Aron-Wisnewsky, François Pattou, Michel Cucherat, Emmanuelle Blondet, Sylvie Lascols, Armms Td Consortium, Dominique Le Guludec, Denis-Jean David, Cédric Carbonneil
OBJECTIVE: . Randomized controlled trials (RCTs) have demonstrated the superiority of metabolic surgery (MS) over medical therapy (MT) in patients with obesity and type 2 diabetes, leading, to a joint statement in 2016 proposing MS to patients with class I obesity and uncontrolled glycemia. Yet, these RCTs included few patients with class I obesity (body mass index 30 to 35 kg/m2 ) and even fewer patients with overweight. Our aim was to provide an updated systematic review (SR) with meta-analysis (MA) of RCTs reporting diabetes remission (DR) after MS in these patients...
November 22, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37992857/masld-hepatic-steatosis-and-fibrosis-are-associated-with-the-prevalence-of-chronic-kidney-disease-and-retinopathy-in-adults-with-type-1-diabetes-mellitus
#27
JOURNAL ARTICLE
Alessandro Mantovani, Mario Luca Morieri, Raffaella Aldigeri, Luisa Palmisano, Maria Masulli, Katia Bonomo, Marco Giorgio Baroni, Efisio Cossu, Flavia Agata Cimini, Gisella Cavallo, Raffaella Buzzetti, Carmen Mignogna, Frida Leonetti, Simonetta Bacci, Roberto Trevisan, Riccardo Maria Pollis, Alessandra Dei Cas, Saula Vigili de Kreutzenberg, Giovanni Targher
AIM: We examined whether metabolic dysfunction-associated steatotic liver disease (MASLD) with or without significant fibrosis (assessed by validated non-invasive biomarkers) was associated with an increased risk of prevalent chronic kidney disease (CKD) or diabetic retinopathy in people with type 1 diabetes mellitus (T1DM). METHODS: We performed a retrospective multicenter cross-sectional study involving 1,409 adult outpatients with T1DM, in whom hepatic steatosis index (HSI) and fibrosis (FIB)-4 index were calculated for non-invasively detecting hepatic steatosis (defined by HSI > 36), with or without coexisting significant fibrosis (FIB-4 index ≥ 1...
November 20, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37981195/glucometrics-knowledge-and-its-relationship-to-glycemic-control-in-people-living-with-type-1-diabetes-the-glukometrics-study-short-running-title-glucometrics-knowledge-and-glycemic-control-in-type-1-diabetes
#28
LETTER
Rebeca Reyes, Oscar Moreno-Perez, Cristina Tejera-Perez, Miguel Brito-Sanfiel, Pedro Pines, Eva Aguilera, Manuel Gargallo, Pedro Rozas-Moreno, Javier Escalada San Martin
No abstract text is available yet for this article.
November 17, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37884124/glucagon-like-peptide-1-receptor-agonists-in-type-1-diabetes
#29
LETTER
Chao Deng, Wenqi Fan, Xia Li
No abstract text is available yet for this article.
November 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37884123/key-indices-of-glycaemic-variability-for-application-in-diabetes-clinical-practice
#30
REVIEW
Louis Monnier, Fabrice Bonnet, Claude Colette, Eric Renard, David Owens
Near normal glycaemic control in diabetes consists to target daily glucose fluctuations and quarterly HbA1c oscillations in addition to overall glucose exposure. Consequently, the prerequisite is to define simple, and mathematically undisputable key metrics for the short- and long-term variability in glucose homeostasis. As the standard deviations (SD) of either glucose or HbA1c are dependent on their means, the coefficient of variation (CV = SD/mean) should be applied instead as it that avoids the correlation between the SD and mean values...
November 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37858922/discontinuation-of-hemodialysis-after-correction-of-a-major-hypothyroidism-episode-a-case-report
#31
LETTER
Sylvie Daclin, Nelly Ramos, Etienne Larger
No abstract text is available yet for this article.
November 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37708990/association-between-different-modalities-of-insulin-administration-and-metabolic-dysfunction-associated-fatty-liver-disease-in-adults-with-type-1-diabetes-mellitus
#32
MULTICENTER STUDY
Alessandro Csermely, Alessandro Mantovani, Mario Luca Morieri, Luisa Palmisano, Maria Masulli, Efisio Cossu, Marco Giorgio Baroni, Katia Bonomo, Flavia Agata Cimini, Gisella Cavallo, Raffaella Buzzetti, Carmen Mignogna, Frida Leonetti, Simonetta Bacci, Roberto Trevisan, Riccardo Maria Pollis, Raffaella Aldigeri, Alessandra Dei Cas, Saula Vigili de Kreutzenberg, Giovanni Targher
AIM: We examined whether different insulin administration modalities, i.e., multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII by insulin pumps), are differently associated with the risk of having metabolic dysfunction-associated fatty liver disease (MAFLD), with or without coexisting significant liver fibrosis (assessed by validated non-invasive biomarkers), in adults with type 1 diabetes mellitus (T1DM). METHODS: We conducted a retrospective, multicenter, cross-sectional study involving 1,417 adult individuals with established T1DM treated with MDI or CSII...
November 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37863470/association-between-diabetes-and-stress-induced-hyperglycemia-with-skeletal-muscle-gene-expression-of-insr-in-critically-ill-patients-a-prospective-cohort-study
#33
JOURNAL ARTICLE
Priscila Bellaver, Ariell F Schaeffer, Diego P Dullius, Daisy Crispim, Cristiane B Leitão, Tatiana H Rech
This study aimed to investigate the association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR of critically ill patients. Skeletal muscle biopsies were prospectively taken from the vastus muscle, and the expression level of INSR was analyzed using RT-qPCR. Fifty patients were included from April 2018 to September 2018. No significant differences in skeletal muscle gene expression were found between patients with or without diabetes. Similarly, there were no differences in gene expression between groups according to the presence of hypoglycemia 〈 70 mg/dl or hyperglycemia 〉 140 mg/dl...
October 18, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37858921/impact-of-chronic-emotions-and-psychosocial-stress-on-glycemic-control-in-patients-with-type-1-diabetes-a-heterogeneity-of-glycemic-responses-biological-mechanisms-and-personalized-medical-treatment
#34
REVIEW
Sylvia Franc, Samir Bensaid, Pauline Schaepelynck, Laurent Orlando, Philippe Lopes, Guillaume Charpentier
Many studies have clearly established that chronic psychosocial stress may sustainably worsen glycemic control in patients with type 1 diabetes mellitus (T1DMM), thus promoting diabetes complications. Chronic psychosocial stress may be due to: i) the long-term accumulation of stressful life events that require readjustment on the part of the individual (loosing friends, changing schools), and/or ii) exposure to severe chronic stressors (persistent difficulties and adversities of life). Whatever the reason, many studies have clearly established a positive correlation between chronic psychosocial stress and HbA1c levels...
October 17, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37689238/hyperglycemia-related-anxiety-during-competition-in-an-elite-athlete-with-type-1-diabetes-a-case-report
#35
JOURNAL ARTICLE
Alexandra Katz, Aidan Shulkin, Meryem K Talbo, Asmaa Housni, Jane Yardley, Anne-Sophie Brazeau, Rémi Rabasa-Lhoret
AIM: Managing blood glucose (BG) levels during intense physical activity is challenging for elite athletes with type 1 diabetes (T1D), as it can lead to unpredictable hyper- or hypoglycemia, which can affect performance. This case study presents an 18-year-old male hockey goalie with hyperglycemia-related anxiety during competition and its impact on his T1D management. METHODS: Mixed-methods approach, incorporating qualitative data from an unstructured interview and responses from the Hyperglycemia Avoidance Scale along with quantitative data retrieved from Diasend and laboratory results...
September 7, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37678758/excessive-dietary-sodium-intake-augments-long-term-risk-of-atrial-fibrillation-in-older-adults-with-hyperglycemia-a-community-based-prospective-cohort-study
#36
JOURNAL ARTICLE
Qin Zhang, Yuqi Guo, Mei Li, Ruizhen Yang, Yanli Yao, Yingxin Zhao, Haipeng Yin, Hua Zhang, Weike Liu, Zhendong Liu
AIM: Studies investigating the association between sodium intake and new-onset atrial fibrillation (AF) have come to controversial results. This study aimed to assess the effect of excessive sodium intake on new-onset AF in individuals with hyperglycemia. METHODS: Between April 2007 and November 2011, 2841 community-dwelling individuals aged 60 years and older were recruited from the Shandong area, China. Dietary sodium intake was estimated using 24-hour urine collection within seven consecutive days...
September 5, 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37678760/do-sglt2-inhibitors-and-glp-1-receptor-agonists-modulate-differently-the-risk-of-stroke-discordance-between-randomised-controlled-trials-and-observational-studies
#37
REVIEW
André J Scheen
Stroke represents a major burden in patients with type 2 diabetes, yet this cerebrovascular complication has been less carefully investigated than the risk of cardiovascular mortality, heart failure and renal disease. Some data suggested that glucagon-like peptide-1 receptor agonists (GLP-1RAs) exert a better protection against stroke than sodium-glucose cotransporter 2 inhibitors (SGLT2is). However, this conclusion was derived from indirect comparisons in absence of any head-to-head randomised controlled trial (RCT)...
September 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37678759/serum-albumin-and-risk-of-incident-diabetes-and-diabetic-microvascular-complications-in-the-uk-biobank-cohort
#38
JOURNAL ARTICLE
Yang-Wei Cai, Hai-Feng Zhang, Jing-Wei Gao, Zhao-Xi Cai, Jie-Wen Cai, Qing-Yuan Gao, Zhi-Teng Chen, Guang-Hong Liao, Chuan-Rui Zeng, Nuo Chen, Pin-Ming Liu, Jing-Feng Wang, Yang-Xin Chen
AIM: To examine the associations between serum albumin and the incidences of diabetes and diabetic microvascular complications in participants of the UK Biobank cohort. METHODS: There were 398,146 participants without diabetes and 30,952 patients with diabetes from the UK Biobank cohort included in this study. Multivariate-adjusted Cox proportional hazard models were used to analyze the association of albumin with the incidences of diabetes and diabetic microvascular complications...
September 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37586479/associations-of-mafld-and-mafld-subtypes-with-the-risk-of-the-incident-myocardial-infarction-and-stroke
#39
JOURNAL ARTICLE
Shen Chen, Hongliang Xue, Rong Huang, Ke Chen, Haoyang Zhang, Xu Chen
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a condition characterized by liver fat accumulation and metabolic abnormalities. Given the potential impact of MAFLD on patient health, it is important to understand its association with major adverse cardiovascular events (MACE) such as myocardial infarction (MI) and stroke. In the prospective UK Biobank cohort, we sought to elucidate the association of MAFLD and its subtypes with incident MI and stroke. In this study, we analyzed the data of 325,129 participants in the UK Biobank and calculated relative risks for MI and stroke using Cox regression analysis...
September 2023: Diabetes & Metabolism
https://read.qxmd.com/read/37451539/effect-of-sglt2-inhibitors-versus-dpp4-inhibitors-on-major-and-non-major-osteoporotic-fracture-risks-among-general-and-high-risk-type-2-diabetes-patients-a-nationwide-retrospective-cohort-study
#40
JOURNAL ARTICLE
Zi-Yang Peng, Yao-Tseng Wang, Chin-Sung Chang, Chih-Hsing Wu, Huang-Tz Ou
AIMS: To retrospectively analyze the association of sodium-glucose cotransporter-2 inhibitors (SGLT2is) versus dipeptidyl peptidase-4 inhibitors (DPP4is) with a range of major and non-major fracture events, and explore heterogeneous treatment effect among high-risk patient subgroups. METHODS: Newly stable SGLT2i or DPP4i users in 2017 were identified in Taiwan's National Health Insurance Research Database and followed up until a fracture occurred, loss of follow-up, death, or December 31, 2018, whichever came first...
September 2023: Diabetes & Metabolism
journal
journal
32535
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.